Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Ombitasvir/paritaprevir/ritonavir 12.5mg/75mg/50mg (Viekirax®)
Ombitasvir/paritaprevir/ritonavir 12.5mg/75mg/50mg (Viekirax®)
NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis
- Traffic Light
Red
- BNF
5.3.3
- Licensed Indicators
Chronic hepatitis C
- Reference
APC Mar 15 APC Sep 15
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik